Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Median Technologies to host two webcasts on September 5, 2024

September 02, 2024 at 11:45 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

“eyonis™ LCS: New Horizons in Fighting Lung Cancer”

Regulatory News:

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.

Following the recent release of results of the eyonis™ LCS REALITY study, Fredrik Brag, CEO and Founder of Median Technologies, will offer further insights into the significance of eyonis™ LCS and discuss the next steps for Median's novel Software as a Medical Device.

September 5, 2024 - 4:00 pm CEST / 10:00 am EDT (English): Sign-up Link
September 5, 2024 - 6:00 pm CEST / 12:00 pm EDT (French): Sign-up Link

Webcast replays will be available on Median’s corporate website shortly after the live sessions.

About Median Technologies: Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240902002418/en/

Contacts

MEDIAN TECHNOLOGIES

Emmanuelle Leygues

Head of Corporate Marketing & Financial Communications

+33 6 10 93 58 88

emmanuelle.leygues@mediantechnologies.com

U.S. media & investors

Chris Maggos

COHESION BUREAU

+41 79 367 6254

chris.maggos@cohesionbureau.com

Investors

Ghislaine Gasparetto

SEITOSEI ACTIFIN

+33 6 21 10 49 24

ghislaine.gasparetto@seitosei-actifin.com

Press

Caroline Carmagnol

ALIZE RP

+33 6 64 18 99 59

median@alizerp.com